✦ LIBER ✦

Five-year disease-free survival of a lung cancer patient treated only by photodynamic therapy

Book ID: 123018941
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 108 KB
Volume: 3
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(87)80109-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term survival of a lung cancer pati

Long-Term survival of a lung cancer patient treated with photodynamic therapy

✍ J. Stuart Nelson; Ronald D. Fairshter; Dr. Michael W. Berns 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

A 63-year-old male, status post-right pneumonectomy, presented with hemoptysis. Although chest X-ray and CAT scan film findings were negative, bronchoscopy with biopsy from the left mainstem bronchus demonstrated squamous cell carcinoma. Because of the inoperable location of the lesion, the patient

Predictive Factors Of Long-term Five Yea

Predictive Factors Of Long-term Five Years Overall Survival Among Patients With Limited Small Cell Lung Cancer Treated With Radiation Treatment And Chemotherapy By Treatment Time Periods

✍ Wei, X.; Allen, P.K.; O'Reilly, M.S.; Fossella, F.V.; Liao, Z.X.; Heymach, J.; H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Serum Vascular Endothelial Growth Factor

Serum Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Can Predict Pathological Response and Disease-Free Survival of Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy

✍ Chiang, Y.; Cheng, J.; Graber, M.; Hsu, F.; Tsai, C.; Lee, J.; Chang, D.; Koong, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB

167 Is 5-year survival rate a real measu

167 Is 5-year survival rate a real measure of outcome in cervix cancer patients treated by radiotherapy? Long-term results in patients treated with external beam radiation therapy and high dose rate brachytherapy

✍ L. Souhami; R. Corns; M. Duclos; G. Stanimir 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 337 KB

NSABP B-42: A Clinical Trial to Determin

NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared with Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor—Positive Breast Cancer

✍ Eleftherios P. Mamounas; Barry Lembersky; Jong-Hyeon Jeong; Walter Cronin; Barba 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB